We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
NEW YORK — The prevalence of substance use disorders is high among patients with schizophrenia, Randall F. White, MD, said in this Healio Video Perspective from the American Psychiatric Association Annual Meeting.
“Some of us find that co-occurring stimulant use disorder [and schizophrenia] is the most challenging thing to treat, because of course stimulants like methamphetamine actually cause psychosis,” White, a clinical professor of psychiatry at The University of British Columbia in Vancouver, told Healio.
White discussed prioritizing the treatment of a patient’s psychosis until they are more stable, at which point the substance abuse disorder can become the focus.
“But that said, it is important to assess and begin some intervention for both disorders as soon as possible,” he said.
